Drug Shortage Report for DIASTAT
Report ID | 177261 |
Drug Identification Number | 02519089 |
Brand name | DIASTAT |
Common or Proper name | DIASTAT |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | DIAZEPAM |
Strength(s) | 15MG |
Dosage form(s) | GEL |
Route of administration | RECTAL |
Packaging size | 2pk |
ATC code | N05BA |
ATC description | ANXIOLYTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-02-10 |
Actual start date | 2023-02-14 |
Estimated end date | 2024-01-19 |
Actual end date | 2024-01-17 |
Shortage status | Resolved |
Updated date | 2024-01-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v32 | 2024-01-18 | English | Compare |
v31 | 2024-01-17 | French | Compare |
v30 | 2024-01-17 | English | Compare |
v29 | 2024-01-10 | French | Compare |
v28 | 2024-01-10 | English | Compare |
v27 | 2023-12-20 | French | Compare |
v26 | 2023-12-20 | English | Compare |
v25 | 2023-12-15 | French | Compare |
v24 | 2023-12-15 | English | Compare |
v23 | 2023-11-01 | French | Compare |
v22 | 2023-11-01 | English | Compare |
v21 | 2023-10-19 | French | Compare |
v20 | 2023-10-19 | English | Compare |
v19 | 2023-09-15 | French | Compare |
v18 | 2023-09-15 | English | Compare |
v17 | 2023-08-23 | French | Compare |
v16 | 2023-08-23 | English | Compare |
v15 | 2023-08-09 | French | Compare |
v14 | 2023-08-09 | English | Compare |
v13 | 2023-07-21 | French | Compare |